Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000491209 | SCV000579684 | likely benign | Hereditary cancer-predisposing syndrome | 2018-02-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001500075 | SCV001704854 | likely benign | Multiple endocrine neoplasia, type 1 | 2022-02-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000553378 | SCV003761879 | uncertain significance | not provided | 2022-07-29 | criteria provided, single submitter | clinical testing | In silico analysis supports that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge; Also known as c.1716C>T; p.(A572=) |